Colette Campbell - Medibank Private Senior Relations
| MPL Stock | 3.83 0.04 1.03% |
Executive
Colette Campbell is Senior Relations of Medibank Private
| Address | 695 Collins Street, Docklands, VIC, Australia, 3008 |
| Phone | 61 3 8622 5222 |
| Web | https://www.medibank.com.au |
Medibank Private Management Efficiency
The company has return on total asset (ROA) of 0.1038 % which means that it generated a profit of $0.1038 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2183 %, meaning that it generated $0.2183 on every $100 dollars invested by stockholders. Medibank Private's management efficiency ratios could be used to measure how well Medibank Private manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Medibank Private's Total Current Liabilities is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 2.5 B in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 3.9 B in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Rebecca Keenan | Wesfarmers | N/A | |
| Amanda McVay | Coles Group | N/A | |
| Damian McGloughlin | Wesfarmers | N/A | |
| Sarah Hunter | Wesfarmers | N/A | |
| Dan Harloe | Wesfarmers | N/A | |
| Giles Hellyer | BHP Group Limited | N/A | |
| Catherine CFA | BHP Group Limited | 42 | |
| James Agar | BHP Group Limited | N/A | |
| Karen OFlynn | Commonwealth Bank | N/A | |
| Paul Burnside | BHP Group Limited | N/A | |
| BA LLB | Wesfarmers | N/A | |
| Huw McKay | BHP Group Limited | N/A | |
| Johan BE | BHP Group Limited | 51 | |
| James Martin | Rio Tinto | N/A | |
| S Tj | Aneka Tambang Tbk | 56 | |
| Archie Norman | Coles Group | 70 | |
| Khaidir Said | Aneka Tambang Tbk | 45 | |
| Julian Longstaff | Commonwealth Bank | N/A | |
| Muhammad Anwar | Aneka Tambang Tbk | 50 | |
| Sharbel ACA | Coles Group | N/A | |
| Anna Croft | Coles Group | N/A | |
Management Performance
Medibank Private Leadership Team
Elected by the shareholders, the Medibank Private's board of directors comprises two types of representatives: Medibank Private inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medibank. The board's role is to monitor Medibank Private's management team and ensure that shareholders' interests are well served. Medibank Private's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medibank Private's outside directors are responsible for providing unbiased perspectives on the board's policies.
| BA BA, Governance Legal | ||
| BA LLB, Legal Trust | ||
| Meaghan Telford, Advocacy Policy | ||
| Felicia Trewin, Group Technology | ||
| BSc BSc, Group Operations | ||
| BEng BSc, Group Strategy | ||
| Fiona Brocq, Acting Officer | ||
| BCom BCom, MD CEO | ||
| Milosh Milisavljevic, Group Portfolios | ||
| BCom MAICD, MD CEO | ||
| Tom Exton, Group Controller | ||
| Peter Kopanidis, Senior Finance | ||
| Emily Ritchie, Senior Affairs | ||
| Colette Campbell, Senior Relations | ||
| FACHSE FRANZCP, Group Health | ||
| Kylie Williamson, Group Operations |
Medibank Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medibank Private a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.22 | |||
| Return On Asset | 0.1 | |||
| Profit Margin | 0.0005 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 10.19 B | |||
| Shares Outstanding | 2.75 B | |||
| Shares Owned By Insiders | 0.12 % | |||
| Shares Owned By Institutions | 42.26 % | |||
| Price To Book | 4.62 X | |||
| Price To Sales | 1.31 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medibank Stock Analysis
When running Medibank Private's price analysis, check to measure Medibank Private's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medibank Private is operating at the current time. Most of Medibank Private's value examination focuses on studying past and present price action to predict the probability of Medibank Private's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medibank Private's price. Additionally, you may evaluate how the addition of Medibank Private to your portfolios can decrease your overall portfolio volatility.